<ul><li>Shares of Aarti Drugs closed 12% higher after receiving 'voluntary action indicated' tag from USFDA for its Tarapur facility</li><li>Clearance allows Aarti Drugs to export products such as Ciprofloxacin HCl API, Zolpidem Tartrate API, Raloxifene HCl API, Celecoxib API, and Niacin API to the US market</li><li>VAI classification indicates that objectionable conditions were found, but not severe enough to attract regulatory action</li><li>Shares of Aarti Drugs rose as much as 17.48% to Rs 497.6 apiece, closing 12.4% higher at Rs 475.90 apiece</li></ul>

Aarti Drugs Shares Close 12% Higher After USFDA Issues 'VAI' Tag For Tarapur Facility

Discover more